Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
34 studies found for:    " August 11, 2010":" September 10, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" August 11, 2010":" September 10, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Circumcision, Male;   Patient Compliance;   Cellular Phone
Intervention: Other: Text Message
2 Completed Reducing HIV in Adolescents
Condition: HIV Infections
Interventions: Behavioral: Cash incentives;   Behavioral: Life skills curriculum
3 Completed
Has Results
Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients
Condition: HIV Infections
4 Completed Could Dietary Algae Affect Immunity and Viral Counts in People With HIV?
Condition: HIV Infections
Intervention: Other: seaweed, spirulina, seaweed + spirulina
5 Completed
Has Results
A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Etravirine;   Drug: Ritonavir;   Drug: Darunavir
6 Unknown  A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
Conditions: HIV Infection;   Gastrointestinal Symptoms
Interventions: Dietary Supplement: GanedenBC30, GBI-30, PTA-6086;   Drug: Placebo
7 Completed Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia
Conditions: HIV Infection;   Tuberculosis;   Immunosuppression
8 Terminated Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression
Conditions: HIV Infection;   Mitochondrial Dysfunction
Interventions: Drug: Atazanavir/ritonavir;   Drug: Efavirenz
9 Completed A Web-based Intervention Study to Reduce High-risk Sexual Behavior by Persons Living With HIV AIDS (PLWH)
Conditions: Sexually Transmitted Infections;   HIV Infections
Intervention: Behavioral: Experimental
10 Completed Affect Management for Early Adolescents
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: General Health Promotion
11 Completed
Has Results
A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures
Conditions: Hepatitis C Infection;   HIV Infection
Intervention: Drug: Nitazoxanide With Pegylated Interferon And Ribavirin
12 Terminated Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761 100 mg once daily;   Drug: GSK2248761 200 mg once daily;   Drug: Etravirine
13 Completed The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance
Conditions: HIV-infection;   Pregnancy;   Mother to Child Transmission
Intervention: Drug: phenytoin
14 Completed KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)
Condition: Antiretroviral Therapy in HIV-1 Infected Children
Interventions: Drug: Kaletra dosed once daily;   Drug: kaletra dosed twice daily
15 Completed Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection
Condition: Acute HIV Infection
Intervention: Behavioral: Standard counseling
16 Completed
Has Results
Atripla to Raltegravir Switch Study for CNS Toxicity
Condition: HIV Infection
Intervention: Drug: Truvada/Raltegravir
17 Active, not recruiting Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas
Conditions: AIDS-Related Diffuse Large Cell Lymphoma;   AIDS-Related Plasmablastic Lymphoma;   AIDS-Related Primary Effusion Lymphoma;   Grade 3b Follicular Lymphoma;   HIV Infection;   Plasmablastic Lymphoma;   Primary Effusion Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Stage I Adult Diffuse Large Cell Lymphoma;   Stage I Grade 3 Follicular Lymphoma;   Stage II Contiguous Adult Diffuse Large Cell Lymphoma;   Stage II Grade 3 Contiguous Follicular Lymphoma;   Stage II Grade 3 Non-Contiguous Follicular Lymphoma;   Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma;   Stage IV Grade 3 Follicular Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Prednisone;   Biological: Rituximab;   Drug: Vincristine Sulfate;   Drug: Vorinostat
18 Completed PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen
Condition: HIV Infection
Intervention: Drug: Maraviroc
19 Recruiting The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
Condition: HIV
Intervention: Procedure: Lymph node biopsy
20 Completed Evaluating Factors That Impact Loss to Follow-up Among Postpartum HIV-infected Women in Mississippi
Condition: HIV

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Indicates status has not been verified in more than two years